Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 December 2024 : Review article  

MicroRNAs as Biomarkers for Metabolic Disorders in Polycystic Ovary Syndrome (PCOS): A Review

Izabela Dymanowska1ABCDEF, Karolina Frankowska ORCID logo2ABCDEF*, Agata Małgorzata Krawczyk2ABCDEF, Julia Kociuba2BCDE, Paulina Gil-Kulik ORCID logo3ABCDEF, Beata Banaszewska ORCID logo4ABCDEF, Grzegorz Polak ORCID logo1ABCDEFG

DOI: 10.12659/MSM.946480

Med Sci Monit 2024; 30:e946480

Authors information Article notes Copyright and License information

Figure 1 The graphic summary of alterations of microRNAs (miRNAs) concentrations associated with lipid profile parameters in patients with polycystic ovary syndrome (PCOS). Lipid metabolism disorders characteristics for PCOS include altered high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglyceride serum concentrations. Each alteration of lipid molecule serum level is regulated by a down- or overexpression of a range of different miRNAs. Based on: [41,48,56,58,67,68,73,99]. Created with BioRender software version 04. HDL-C – high-density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol; miRNA, miR – microRNA.

Back to the Article

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750